Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 4
2007 2
2008 1
2010 6
2011 2
2012 1
2013 1
2014 2
2016 2
2017 2
2018 1
2019 1
2021 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Comorbidities and their impact on chronic obstructive pulmonary disease.
Dursunoğlu N, Köktürk N, Baha A, Bilge AK, Börekçi Ş, Çiftçi F, Gezmen Karadağ M, Çalık Kütükçü E, Noyan A, Polatlı M, Önen ZP, Sarınç S, Umut S, Uzaslan E, Kubat Üzüm A, Akkoca Yıldız Ö; Turkish Thoracic Society- COPD Comorbidity Group. Dursunoğlu N, et al. Among authors: onen zp. Tuberk Toraks. 2016 Dec;64(4):289-298. Tuberk Toraks. 2016. PMID: 28393718 Review. English.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4. Lancet Respir Med. 2024. PMID: 38548406 Clinical Trial.
Triggers of asthma and COPD: are they different?
Aydin Ö, Çelik GE, Önen ZP, Yilmaz İ, Özdemir SK, Yildiz Ö, Mungan D, Demirel YS. Aydin Ö, et al. Among authors: onen zp. Allergol Immunopathol (Madr). 2013 Jan-Feb;41(1):30-6. doi: 10.1016/j.aller.2011.07.004. Epub 2011 Oct 2. Allergol Immunopathol (Madr). 2013. PMID: 21968007
How do patients with asthma and COPD behave during fasting?
Aydin O, Celik GE, Onen ZP, Yilmaz I, Ozdemir SK, Yildiz O, Mungan D, Demirel YS. Aydin O, et al. Among authors: onen zp. Allergol Immunopathol (Madr). 2014 Mar-Apr;42(2):115-9. doi: 10.1016/j.aller.2012.07.010. Epub 2012 Dec 21. Allergol Immunopathol (Madr). 2014. PMID: 23265268
The factors affecting survival in patients with bronchiectasis.
Çiftçi F, Şen E, Saryal SB, Önen ZP, Gülbay B, Yıldız Ö, Acıcan T, Karabıyıkoğlu G. Çiftçi F, et al. Among authors: onen zp. Turk J Med Sci. 2016 Dec 20;46(6):1838-1845. doi: 10.3906/sag-1511-137. Turk J Med Sci. 2016. PMID: 28081336 Free article.
Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study.
Küçükoğlu MS, Hanta İ, Akdeniz B, Güllülü S, Atahan E, Sayın T, Okumuş G, Önen ZP, Yokuşoğlu M, Baygül A. Küçükoğlu MS, et al. Among authors: onen zp. Anatol J Cardiol. 2021 Oct;25(10):721-732. doi: 10.5152/AnatolJCardiol.2021.03009. Anatol J Cardiol. 2021. PMID: 34622787 Free PMC article.
Diagnosis and Treatment Patterns of Chronic Thromboembolic Pulmonary Hypertension in Russia, Kazakhstan, Turkey, Lebanon, and Saudi Arabia: A Registry Study.
Öngen HG, Akdeniz B, Düzenli MA, Chernyavsky A, Dabar G, Idrees M, Khludeeva E, Kültürsay H, Lukianchikova V, Martynyuk T, Moğulkoç N, Mukarov MA, Mutlu B, Okumuş G, Omarov A, Önen ZP, Sakkijha H, Shostak N, Simakova M, Tokgözoğlu L, Tomskaya T, Yildirim H, Zateyshchikov D, Hechenbichler K, Kessner S, Schauerte I, Turgut N, Vogtländer K, Aldalaan A; CTEPH EMEA Registry Investigators. Öngen HG, et al. Among authors: onen zp. Drugs Real World Outcomes. 2024 Mar;11(1):149-165. doi: 10.1007/s40801-023-00407-w. Epub 2024 Feb 21. Drugs Real World Outcomes. 2024. PMID: 38381283 Free PMC article.
26 results